Marijuana Company of America, Inc. (MCOA) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $2.21M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerMarijuana Company of America, Inc. (MCOA) trades at $0.0001. Marijuana Company of America, Inc. develops and distributes cannabis and CBD products under the hempSMART brand. Market cap: $2.21M, Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for MCOA: MCOA does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Marijuana Company of America, Inc. (MCOA) Healthcare & Pipeline Overview
Marijuana Company of America, Inc. focuses on developing and distributing cannabis and CBD products under the hempSMART brand, targeting the wellness market through online and affiliate channels, while facing significant challenges in profitability and market competition within the specialty drug manufacturing sector.
What Is the Investment Thesis for MCOA?
Investing in Marijuana Company of America, Inc. presents significant risks due to its negative profitability and high beta of 9.91, indicating extreme volatility relative to the market. The company's negative profit margin of -1441.1% and gross margin of -74.1% raise concerns about its financial sustainability. Growth depends on successful expansion of the hempSMART product line and effective marketing strategies to increase sales through online and affiliate channels. Potential investors should carefully consider the risks associated with OTC-listed companies and the competitive landscape of the cannabis and CBD market. The company's small size, with only 7 employees, also poses operational challenges.
Based on FMP financials and quantitative analysis
MCOA Key Highlights
Market capitalization of $2.21M indicates a micro-cap company with limited financial resources.
- P/E ratio of -0.09 reflects negative earnings and challenges in achieving profitability.
- Profit margin of -1441.1% highlights significant losses and operational inefficiencies.
- Gross margin of -74.1% indicates that the cost of goods sold exceeds revenue, posing a substantial challenge to the company's business model.
- Beta of 9.91 suggests extreme volatility compared to the broader market, making it a high-risk investment.
Who Are MCOA's Competitors?
MCOA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
| TXMD TherapeuticsMD, Inc. | $2.05 | +0.99% | $23.7M | — |
| CPHI CPHI | $0.66 | +0.61% | $26.6M | — |
| SCYX SCYNEXIS, Inc. | $5.12 | -4.66% | $32.2M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MCOA's Key Strengths?
Established hempSMART brand.
- Proprietary formulations like hempSMART Brain.
- Distribution network through cdistro.com.
- Direct-to-consumer sales channel.
What Are MCOA's Weaknesses?
Negative profitability and gross margins.
- High beta indicating extreme volatility.
- Limited financial resources.
- Small employee base.
What Are the Key Risks for MCOA?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition in the cannabis and CBD market, which could erode MCOA's market share.
- Complex and evolving regulatory landscape, which could impact MCOA's ability to operate and sell its products.
- Fluctuations in consumer demand for cannabis and CBD products.
- Potential for product recalls or safety concerns, which could damage MCOA's brand reputation.
- Negative profitability and gross margins, which could threaten MCOA's financial sustainability.
What Are MCOA's Competitive Advantages?
- Brand recognition of hempSMART products.
- Proprietary formulations, including hempSMART Brain.
- Established distribution network through cdistro.com.
- Affiliate marketing program driving sales.
What Does MCOA Do?
Marijuana Company of America, Inc. (MCOA) was founded in 1985 as Converge Global, Inc., before rebranding in December 2015 to capitalize on the emerging cannabis and CBD market. The company develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand within the United States. MCOA's product line includes hempSMART Brain, a patented personal care product for brain wellness; hempSMART Pain capsules and cream for discomfort relief; hempSMART Drops, a hemp CBD oil tincture; hempSMART Pet Drops for cats and dogs; hempSMART Face, a facial moisturizer; and hempSMART drink mix, a powderized CBD drink. These products are primarily sold through the company's website and affiliate marketing programs. Additionally, MCOA distributes hemp and CBD products, including smoke and vape shop related items, to wholesalers, c-stores, specialty retailers, and consumers through its cdistro.com platform. Headquartered in Los Angeles, California, MCOA aims to establish a presence in the growing CBD and cannabis wellness market.
What Products and Services Does MCOA Offer?
- Develops and produces cannabis and cannabidiol (CBD) products.
- Distributes products under the hempSMART brand.
- Offers hempSMART Brain for brain wellness.
- Provides hempSMART Pain capsules and cream for discomfort relief.
- Sells hempSMART Drops, a hemp CBD oil tincture.
- Markets hempSMART Pet Drops for cats and dogs.
- Offers hempSMART Face, a facial moisturizer.
- Distributes hemp and CBD products through www.cdistro.com.
How Does MCOA Make Money?
- Develops and manufactures hempSMART branded CBD and cannabis products.
- Sells products directly to consumers through its website.
- Distributes products through affiliate marketing programs.
- Wholesales hemp and CBD products to retailers via cdistro.com.
What Industry Does MCOA Operate In?
Marijuana Company of America, Inc. operates in the rapidly evolving cannabis and CBD market, which is characterized by increasing consumer demand for wellness products. The industry is highly competitive, with numerous companies vying for market share. MCOA faces competition from established players and emerging brands. The regulatory landscape is complex and varies by state, creating both opportunities and challenges for companies in this sector. The global cannabis market is projected to reach significant growth in the coming years, driven by increasing legalization and acceptance of cannabis and CBD products.
Who Are MCOA's Key Customers?
- Individual consumers seeking wellness and pain relief products.
- Retailers, including smoke shops, vape shops, and c-stores.
- Wholesalers distributing hemp and CBD products.
- Affiliate marketers promoting hempSMART products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Marijuana Company of America, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Los Angeles, US. The company is led by CEO Jesus Quintero. MCOA has traded publicly since 1999.
How Marijuana Company of America, Inc. Is Valued
Marijuana Company of America, Inc. carries a market capitalization of $2.21M, placing it in the micro-cap category.
Key Financial Metrics
Return on equity for Marijuana Company of America, Inc. stands at 328.6%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Marijuana Company of America, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Insider Activity
12 transactions · 3 purchases, 7 sales, 2 other transactions · 2 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
MCOA Financials
MCOA Latest News
No recent news available for MCOA.
MCOA Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MCOA.
Price Targets
Wall Street price target analysis for MCOA.
MCOA MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MCOA; grades run from A+ (80-100) to F (below 30).
Leadership: Jesus Quintero
CEO
Jesus Quintero serves as the CEO of Marijuana Company of America, Inc. His background includes experience in managing and developing businesses, with a focus on the cannabis and CBD industry. He has been instrumental in guiding the company's strategic direction and product development efforts. His expertise lies in identifying market opportunities and building partnerships to expand the company's reach. He is responsible for overseeing all aspects of the company's operations, from product development to sales and marketing.
Track Record: Under Jesus Quintero's leadership, Marijuana Company of America, Inc. has focused on expanding its hempSMART product line and establishing a presence in the competitive CBD market. Key milestones include the development of hempSMART Brain and the expansion of the company's online sales channels. He has also focused on building relationships with affiliate marketers to drive sales and increase brand awareness. His tenure has been marked by efforts to navigate the evolving regulatory landscape and position the company for growth.
MCOA OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Marijuana Company of America, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and increased volatility. This tier is often populated by shell companies, companies in distress, or those with minimal operations.
- OTC Tier: OTC Other
- Limited financial disclosure and potential for lack of transparency.
- Low trading volume and illiquidity.
- Higher risk of fraud or manipulation.
- Limited regulatory oversight and investor protection.
- Potential for delisting or suspension of trading.
- Verify the company's legal standing and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- Established hempSMART brand.
- Online presence and direct-to-consumer sales channel.
- Distribution network through cdistro.com.
- Management team in place.
Common Questions About MCOA (Healthcare)
What do analysts say about MCOA stock?
As of 2026-03-17, there is no available analyst coverage for Marijuana Company of America, Inc. due to its OTC listing and small market capitalization.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available due to OTC listing.
- Financial data may not be fully reliable.